These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26019217)

  • 21. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High-dose heat shock protein gp96 immunization prevents type 1 diabetes via inducing regulatory T cells].
    Chen M; Li X; Zheng H; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2016 Dec; 32(12):1685-1693. PubMed ID: 29034636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of a T cell agonist peptide to lysosomes by DNA vaccination induces tolerance in the nonobese diabetic mouse.
    Rivas EI; Driver JP; Garabatos N; Presa M; Mora C; Rodriguez F; Serreze DV; Stratmann T
    J Immunol; 2011 Apr; 186(7):4078-87. PubMed ID: 21346228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137
    Foda BM; Ciecko AE; Serreze DV; Ridgway WM; Geurts AM; Chen YG
    J Immunol; 2020 Jun; 204(11):2887-2899. PubMed ID: 32295876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.
    Prasad S; Kohm AP; McMahon JS; Luo X; Miller SD
    J Autoimmun; 2012 Dec; 39(4):347-53. PubMed ID: 22647732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
    Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ectopic Expression of Self-Antigen Drives Regulatory T Cell Development and Not Deletion of Autoimmune T Cells.
    Lee T; Sprouse ML; Banerjee P; Bettini M; Bettini ML
    J Immunol; 2017 Oct; 199(7):2270-2278. PubMed ID: 28835461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice.
    Kornete M; Sgouroudis E; Piccirillo CA
    J Immunol; 2012 Feb; 188(3):1064-74. PubMed ID: 22227569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides.
    Li M; Itoh A; Xi J; Yu C; Wu Y; Ridgway WM; Liu H
    J Immunol; 2021 Oct; 207(8):2051-2059. PubMed ID: 34526376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-33 prevents the development of autoimmune diabetes in NOD mice.
    Lu J; Liang Y; Zhao J; Meng H; Zhang X
    Int Immunopharmacol; 2019 May; 70():9-15. PubMed ID: 30780005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
    Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
    J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An altered CD8
    Zhang M; Wang S; Guo B; Meng G; Shu C; Mai W; Zheng Q; Chen X; Wu Y; Wang L
    Cell Mol Immunol; 2019 Jun; 16(6):590-601. PubMed ID: 29955175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk.
    Mátrai J; Cantore A; Bartholomae CC; Annoni A; Wang W; Acosta-Sanchez A; Samara-Kuko E; De Waele L; Ma L; Genovese P; Damo M; Arens A; Goudy K; Nichols TC; von Kalle C; L Chuah MK; Roncarolo MG; Schmidt M; Vandendriessche T; Naldini L
    Hepatology; 2011 May; 53(5):1696-707. PubMed ID: 21520180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BDC12-4.1 T-cell receptor transgenic insulin-specific CD4 T cells are resistant to in vitro differentiation into functional Foxp3+ T regulatory cells.
    Sarikonda G; Fousteri G; Sachithanantham S; Miller JF; Dave A; Juntti T; Coppieters KT; von Herrath M
    PLoS One; 2014; 9(11):e112242. PubMed ID: 25393309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.
    Aghili B; Amirzargar AA; Rajab A; Rabbani A; Sotoudeh A; Assadiasl S; Larijani B; Massoud A
    Iran J Immunol; 2015 Dec; 12(4):240-51. PubMed ID: 26714416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.
    Gregori S; Battaglia M; Roncarolo MG
    Novartis Found Symp; 2008; 292():174-83; discussion 183-6, 202-3. PubMed ID: 19203099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells.
    Tsai S; Serra P; Clemente-Casares X; Yamanouchi J; Thiessen S; Slattery RM; Elliott JF; Santamaria P
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3471-6. PubMed ID: 23401506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells.
    Jamison BL; Neef T; Goodspeed A; Bradley B; Baker RL; Miller SD; Haskins K
    J Immunol; 2019 Jul; 203(1):48-57. PubMed ID: 31109955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.